Pharmaceutical Company CEO Developing $100 Alternative To EpiPen After 'Shameful' Price Hike

September 4, 2016

Mark Baum, CEO of Imprimis Pharmaceuticals who previously came out with a $1 alternative to Martin Shkreli's AIDS drug after 5000% price hike, is now going to take on Mylan and is plotting to offer a $100 EpiPen alternative.

epipen alternative
Mark Baum / Imprimis Pharmceuticals

Baum believes the relentless EpiPen price hikes are "shameful" and plans to have a compounded version of the allergy treatment by the end of the year.

"I don't need to make $19 million a year," Baum said, referring to the big pay package Mylan's CEO Heather Bresch took home last year.

"Tonight when I go home I'm going to eat a nice piece of fish and the fish I eat isn't any better or worse than what she is going to eat."

Like us on Facebook!

Click Here For The Most Popular On Sunny Skyz

feel good videoWatch A Perplexed Beaver Become The Accidental Leader Of 150 Cows

feel good storiesFamily Plays Horror Board Game And Gets More Than They Bargained For

feel good storiesThe 10 Funniest Sibling Photo Recreations On The Internet

feel good storiesIKEA's Brilliant Response To Fashion Company's $2610 Version Of Their $1 Blue Bag

feel good storiesWhat Becoming A Billionaire Actually Feels Like

feel good storiesThis Girl Made A 'Why You Should Date Me' Powerpoint For Her Crush

feel good videoNews Anchors Learn What A 'Furry' Is Live On Camera

feel good videoThis Kitten Was Abandoned, Then A Crow Does Something You've Never Seen

feel good videoThe Internet Can't Handle This Video Of A Baby Adoring His Mom

feel good videoComedian Has To Stop His Routine Because Of The Noise Coming From This Guy

feel good videoWatch A Perplexed Beaver Become The Accidental Leader Of 150 Cows